A Randomized, Double-blind, Placebo-controlled, Parallel, Single Center Study to Investigate the Pharmacokinetics, Safety, Tolerability, and QT Concentration-effect Modelling of Estetrol in Combination With Drospirenone After Single and Multiple Dosing in Healthy Women
Phase of Trial: Phase I
Latest Information Update: 25 Apr 2017
At a glance
- Drugs Drospirenone/estetrol (Primary)
- Indications Pregnancy
- Focus Pharmacokinetics
- Sponsors Estetra S.A.
- 20 Apr 2017 Status changed from active, no longer recruiting to completed.
- 12 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Apr 2017.
- 25 Aug 2016 New trial record